We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-9.57%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$1.21B
AUM Growth
+$57.1M
Cap. Flow
+$88M
Cap. Flow %
7.29%
Top 10 Hldgs %
18.29%
Holding
1,231
New
406
Increased
209
Reduced
153
Closed
411
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
701
Viking Therapeutics
VKTX
$3.88B
$112K 0.01%
24,016
CHR icon
702
Cheer Holding
CHR
$3.51M
$110K 0.01%
18
-26
-59% -$246K
CTMX icon
703
CytomX Therapeutics
CTMX
$736M
$107K 0.01%
+13,900
New +$96.9K
DHT icon
704
DHT Holdings
DHT
$2.96B
$107K 0.01%
+14,011
New +$88.8K
MXF
705
Mexico Fund
MXF
$315M
$105K 0.01%
+12,621
New +$158K
TUP
706
DELISTED
Tupperware Brands Corporation
TUP
$105K 0.01%
+65,000
New +$331K
QVCGA
707
DELISTED
QVC Group Inc Series A
QVCGA
$103K 0.01%
+348
New +$124K
TBIO
708
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$101K 0.01%
+10,100
New +$82.7K
BCOV
709
DELISTED
Brightcove, Inc.
BCOV
$99K 0.01%
+14,200
New +$114K
LBRT icon
710
Liberty Energy
LBRT
$3.33B
$98K 0.01%
36,311
+14,460
+66% +$101K
VIVO
711
DELISTED
Meridian Bioscience Inc
VIVO
$96K 0.01%
+11,400
New +$96K
BTU icon
712
Peabody Energy
BTU
$2.9B
$95K 0.01%
32,600
+18,537
+132% +$119K
SIOX
713
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$95K 0.01%
38,800
TEN
714
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$95K 0.01%
+26,400
New +$222K
ONDK
715
DELISTED
On Deck Capital, Inc.
ONDK
$95K 0.01%
61,417
+17,366
+39% +$56.6K
FLEX icon
716
Flex
FLEX
$45.5B
$92K 0.01%
+14,597
New +$126K
PGNX
717
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$92K 0.01%
24,144
-10,000
-29% -$43.1K
PAE
718
DELISTED
PAE Incorporated Class A Common Stock
PAE
$91K 0.01%
+13,969
New +$136K
ATRS
719
DELISTED
Antares Pharma, Inc.
ATRS
$90K 0.01%
+37,998
New +$129K
PBYI icon
720
Puma Biotechnology
PBYI
$410M
$89K 0.01%
10,539
-42,750
-80% -$415K
BW icon
721
Babcock & Wilcox
BW
$1.41B
$88K 0.01%
86,421
+24,436
+39% +$88.2K
OVV icon
722
Ovintiv
OVV
$16.4B
$88K 0.01%
32,575
+30,523
+1,487% +$401K
CALA
723
DELISTED
Calithera Biosciences, Inc
CALA
$87K 0.01%
+980
New +$117K
GLUU
724
DELISTED
Glu Mobile Inc.
GLUU
$87K 0.01%
+13,900
New +$89.6K
AA icon
725
Alcoa
AA
$12.7B
$86K 0.01%
+13,954
New +$191K

Similar funds

Boothbay Fund Management's Q1 2020 Portfolio in Review

As of Q1 2020, Boothbay Fund Management held 1,231 positions worth $1.21B, up 5% from $1.15B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boothbay Fund Management deployed $88M of net new capital in Q1 2020, opening 406 new positions and adding to 209 existing holdings. Its largest new stake was Sprott Physical Gold: 1,601,344 shares worth $21M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $6M trimmed.

  • Boothbay Fund Management's largest Q1 2020 buy was Sprott Physical Gold: 1,601,344 shares worth $21M.
  • Boothbay Fund Management added most to Allergan plc in Q1 2020, an estimated $37.1M increase.
  • Boothbay Fund Management's biggest Q1 2020 reduction was NXP Semiconductors, cutting an estimated $6M.
  • Boothbay Fund Management fully exited Sprott Physical Gold and Silver Trust in Q1 2020, selling an estimated $18.8M.
  • Boothbay Fund Management's ten largest holdings make up 18% of its $1.21B portfolio in Q1 2020.
  • Boothbay Fund Management opened 406 new positions and closed 411 in Q1 2020.
  • Boothbay Fund Management's portfolio value rose 5% quarter-over-quarter to $1.21B.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.